These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2190436)

  • 21. Comparison of piroxicam with indomethacin in ankylosing spondylitis: a double-blind crossover trial.
    Sydnes OA
    Br J Clin Pract; 1981 Jan; 35(1):40-4. PubMed ID: 7020732
    [No Abstract]   [Full Text] [Related]  

  • 22. Repeated cyclosporine therapy of peripheral arthritis associated with ankylosing spondylitis.
    Géher P; Gömör B
    Med Sci Monit; 2001; 7(1):105-7. PubMed ID: 11208503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of indoprofen and indomethacin in the treatment of ankylosing spondylitis.
    Armstrong RD; Laurent R; Panayi GS
    Pharmatherapeutica; 1984; 3(10):637-41. PubMed ID: 6379678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ankylosing spondylitis and symptom-modifying vs disease-modifying therapy.
    Akkoc N; van der Linden S; Khan MA
    Best Pract Res Clin Rheumatol; 2006 Jun; 20(3):539-57. PubMed ID: 16777581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind comparison of tolmetin sodium and indomethacin in ankylosing spondylitis.
    Esdaile J; Rothwell R; MacLaughlin K; Percy J; Hawkins D
    J Rheumatol; 1982; 9(1):69-74. PubMed ID: 7045363
    [No Abstract]   [Full Text] [Related]  

  • 26. [Ankylosing spondylitis. Comparative trial of two non-steroidal anti-inflammatory agents: pirprofen and ketoprofen].
    Renier JC; Fournier M; Loyau G; Roux H
    Nouv Presse Med; 1982 Aug; 11(33):2494-6. PubMed ID: 6752874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The role of biologic agents in the therapy of ankylosing spondylitis].
    Géher P; Nagy MB; Péntek M; Tóth E; Brodszky V; Gulácsi L
    Orv Hetil; 2006 Jul; 147(26):1203-13. PubMed ID: 16898082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis.
    van Denderen JC; van der Paardt M; Nurmohamed MT; de Ryck YM; Dijkmans BA; van der Horst-Bruinsma IE
    Ann Rheum Dis; 2005 Dec; 64(12):1761-4. PubMed ID: 15901634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study.
    Clegg DO; Reda DJ; Abdellatif M
    Arthritis Rheum; 1999 Nov; 42(11):2325-9. PubMed ID: 10555027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of flurbiprofen with naproxen in ankylosing spondylitis.
    Burry HC; Siebers R
    N Z Med J; 1980 Oct; 92(670):309-11. PubMed ID: 7003449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index.
    Heuft-Dorenbosch L; van Tubergen A; Spoorenberg A; Landewé R; Dougados M; Mielants H; van der Tempel H; van der Heijde D
    Arthritis Rheum; 2004 Apr; 51(2):154-9. PubMed ID: 15077254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etanercept: new indication. For ankylosing spondylitis: another option.
    Prescrire Int; 2005 Jun; 14(77):92-3. PubMed ID: 15981387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-inflammatory treatment of ankylosing spondylitis (author's transl)].
    Doury P; Pattin S
    Sem Hop; 1980 Jan 8-15; 56(1-2):89-91. PubMed ID: 6244637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of naproxen and piroxicam in rheumatoid arthritis and Bechterew's syndrome. A double-blind parallel multicenter study].
    Myklebust G
    Tidsskr Nor Laegeforen; 1986 Jun; 106(17-18):1485-7. PubMed ID: 3532419
    [No Abstract]   [Full Text] [Related]  

  • 35. Tolfenamic acid in ankylosing spondylarthritis: a double-blind comparison to indomethacin.
    Rejholec V; Vapaatalo H; Tokola O; Gothoni G
    Scand J Rheumatol Suppl; 1980; 36():1-7. PubMed ID: 7013054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of refractory inflammatory monoarthritis in ankylosing spondylitis by intraarticular injection of infliximab.
    Schatteman L; Gyselbrecht L; De Clercq L; Mielants H
    J Rheumatol; 2006 Jan; 33(1):82-5. PubMed ID: 16292792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The evaluation of the therapeutic efficacy of auranofin in juvenile rheumatoid arthritis (the results of Soviet-American research)].
    Kuz'mina NN; Brue E; Shaĭkov AV; Isaeva LA; Shakhbazian IE; Giannini E; Iakovleva AA; Puodzhiunene EP; Vorontsov IM; Astrauskene DS
    Ter Arkh; 1990; 62(5):38-41. PubMed ID: 2204140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gold preparations in therapy of rheumatoid and psoriatic arthritis].
    Nasonova VA; Lukina GV; Sigidin IaA; Badokin VV
    Ter Arkh; 2003; 75(5):88-90. PubMed ID: 12847908
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ankylosing spondylitis with and without peripheral joint involvement. The significance of HLA-DR4 in the diagnosis, disease risk and pathogenesis].
    Miehle W; Schattenkirchner M; Albert D; Bunge M
    Fortschr Med; 1984 Jun; 102(21):581-5. PubMed ID: 6590449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis.
    Champion GD; Cairns DR; Bieri D; Adena MA; Browne CD; Cohen ML; Day RO; Edmonds JP; Graham GG; de Jager J
    J Rheumatol; 1988 Jan; 15(1):28-34. PubMed ID: 3280795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.